Skip to content

Photoscreening for Retinoblastoma

Prospective Evaluation of a Smartphone Application, GoCheckKids TM, as a Screening Tool for Leukocoria in the Infant and Pediatric Population

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04344652
Enrollment
0
Registered
2020-04-14
Start date
2022-06-01
Completion date
2022-06-01
Last updated
2025-09-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinoblastoma

Brief summary

Retinoblastoma is the most common pediatric eye malignancy and manifests between 1 and 5 years of age. The tumor is most often diagnosed by leukocoria ( white reflex in the pupil). There is often a significant delay in diagnosis and early diagnosis enables good life prognosis and better vision outcome.There is currently not a standardized screening protocol for detection of retinoblastoma. Vision screening methods are recommended for children 3-5 years of age. The investigators are attempting to use instrument based screening started from birth to detect leukocoria.

Interventions

DEVICEPhotoscreening -

external picture taken with a an phone based app

Sponsors

Phoenix Children's Hospital
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Intervention model description

Single visit cross sectional prospective study

Eligibility

Sex/Gender
ALL
Age
0 Years to 10 Years
Healthy volunteers
Yes

Inclusion criteria

* Age birth to 10 years * Informed consent given by parent or legal guardian

Exclusion criteria

* None

Design outcomes

Primary

MeasureTime frameDescription
Reliability to detect leukocoria1 yearTesting the reliability of the app to detect leukocoria with good sensitivity and specificity

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026